Sensei Biotherapeutics, Inc.
SNSE
$12.63
-$0.37-2.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 202.79M | 21.18M | 25.04M | 28.63M | 34.33M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 974.00K | 231.00K | 496.00K | 828.00K | 911.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 465.00K | 92.00K | 248.00K | 116.00K | 440.00K |
| Total Current Assets | 204.23M | 21.51M | 25.79M | 29.57M | 35.68M |
|
|
|||||
| Total Current Assets | 204.23M | 21.51M | 25.79M | 29.57M | 35.68M |
| Net Property, Plant & Equipment | 982.00K | 1.38M | 1.79M | 2.19M | 2.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 167.00K | 18.00K | 18.00K | 24.00K | 24.00K |
| Total Assets | 205.38M | 22.90M | 27.59M | 31.78M | 38.27M |
|
|
|||||
| Total Accounts Payable | 3.42M | 689.00K | 306.00K | 351.00K | 361.00K |
| Total Accrued Expenses | 9.60M | 2.04M | 2.18M | 1.48M | 2.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.04M | 1.45M | 1.88M | 1.96M | 2.15M |
| Total Finance Division Other Current Liabilities | 136.00K | 77.00K | 80.00K | 80.00K | 88.00K |
| Total Other Current Liabilities | 136.00K | 77.00K | 80.00K | 80.00K | 88.00K |
| Total Current Liabilities | 14.19M | 4.25M | 4.44M | 3.87M | 5.23M |
|
|
|||||
| Total Current Liabilities | 14.19M | 4.25M | 4.44M | 3.87M | 5.23M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 59.00K | 146.00K | 596.00K | 1.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 328.48M | -- | -- | -- | -- |
| Total Liabilities | 342.67M | 4.31M | 4.58M | 4.47M | 6.29M |
|
|
|||||
| Common Stock & APIC | 316.11M | 301.73M | 301.43M | 301.18M | 300.91M |
| Retained Earnings | -453.37M | -283.14M | -278.42M | -273.85M | -268.92M |
| Treasury Stock & Other | -24.00K | 1.00K | -3.00K | -11.00K | -6.00K |
| Total Common Equity | -137.29M | 18.59M | 23.01M | 27.31M | 31.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -137.29M | 18.59M | 23.01M | 27.31M | 31.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -137.29M | 18.59M | 23.01M | 27.31M | 31.99M |
|
|
|||||